首页> 美国卫生研究院文献>Cancer Imaging >Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors

【2h】

Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors

机译：评估18F-FDG PET-CT对晚期或复发性胸腺上皮肿瘤患者的代谢反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundPatients with advanced or recurrent thymic epithelial tumors (TETs) often need several consecutive lines of chemotherapy. The aim of this retrospective monocentric study was to test whether ¹⁸F-Fluorodeoxyglucose positron emission tomography-computed tomography (¹⁸F-FDG PET-CT) is able to monitor standard chemotherapy efficacy in those patients and whether metabolic response correlates with morphovolumetric response as assessed by Response Evaluation Criteria in Solid Tumor (RECIST).

机译：背景患有晚期或复发性胸腺上皮肿瘤（TET）的患者通常需要连续进行几系化疗。这项回顾性单中心研究的目的是检验^{18 F-去氧葡萄糖葡萄糖正电子发射断层扫描计算机断层扫描（^{18 F-FDG PET-CT）是否能够监测标准化疗如实体瘤反应评估标准（RECIST）所评估，这些药物对这些患者的疗效以及代谢反应是否与形态容量反应相关。}}

著录项

期刊名称 Cancer Imaging
作者
Sabrina Segreto; Rosa Fonti; Margaret Ottaviano; Sara Pellegrino; Leonardo Pace; Vincenzo Damiano; Giovannella Palmieri; Silvana Del Vecchio;
展开▼
作者单位

展开▼
年(卷),期 2017(17),-1
年度 2017
页码 10
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Thymoma Thymic carcinoma sup18/supF-FDG PET-CT Tumor response RECIST;

机译：胸腺瘤;胸腺癌;sup 18 / sup F-FDG PET-CT;肿瘤反应;RECIST;

相似文献

外文文献
中文文献
专利

1. Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors [J] . Sabrina Segreto, Rosa Fonti, Margaret Ottaviano, Cancer Imaging . 2017,第Suppla1期

机译：用18F-FDG PET-CT对晚期或复发性胸腺上皮肿瘤患者的代谢反应进行评估
2. Evaluation of thymic tumors with 18F-FDG PET-CT: A pictorial review [J] . SharmaP., SinghalA., KumarA., Acta Radiologica . 2013,第1期

机译：用18F-FDG PET-CT评估胸腺肿瘤：图片审查
3. Emerging treatment options for patients with recurrent advanced thymic epithelial tumors [J] . Tracey L Evans OncoTargets and therapy . 2012,第6期

机译：复发性晚期胸腺上皮肿瘤患者的新兴治疗选择
4. Quantification of Local Metabolic Tumor Volume Changes by Registering Blended PET-CT Images for Prediction of Pathologic Tumor Response [C] . Sadegh Riyahi, Wookjin Choi, Chia-Ju Liu, Data driven treatment response assessment and preterm, perinatal, and paediatric image analysis . 2018

机译：通过注册混合PET-CT图像来预测病理性肿瘤反应，量化局部代谢性肿瘤的体积变化
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. Emerging treatment options for patients with recurrent advanced thymic epithelial tumors [O] . Tracey L Evans 2012

机译：复发性晚期胸腺上皮肿瘤患者的新兴治疗选择
7. Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. [O] . Segreto, S, Fonti, R, Ottaviano, M, 2017

机译：评价18F-FDG pET-CT对晚期或复发性胸腺上皮肿瘤患者的代谢反应。

Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors

摘要

著录项

相似文献

相关主题

期刊订阅